Anavex Life Sciences Corp (AVXL)

[skitahoe]

Boi, investors in NWBO had a similar experience while waiting for its GBM vaccine, DCVax-L to be published. Many knowledgeable posters thought it would be faster, many guessed that it would be in NEJM or Lancet. No one thought of JAMA Oncology, but that's where it was published. We're now awaiting a publication in Nature, we know it's under review and has been for many months. My point is, no one really knows how long these things will take. The UK may very well approve DCVax-L before the Nature publication is out, and who knows, perhaps that's what they want. If the UK's 150 day review applies, we'll have a decision before the end of May.

Almost every biotech I've ever observed operates with far more secrecy than investors believe they should, that's one reason I'm not that critical of the CEO, no one knows what's happening behind the scenes. I'm a new investor here, though I've watched the company for years. I believe those here who've said the staff that's been assembled are quite competent to develop the packages that must be submitted to the different regulators. I would suspect that over 90% or the package are common between the regulators, but the remainder is specific to the regulator, and all must be just right. I believe in time we'll all be well rewarded, regardless of who the CEO is at that time.

Gary